Osteo Dense Formula

Osteo Dense Formula X035

Osteo Dense Formula

�17.99

Elixir is proud to announce the launch of Ipriflavone, a ground breaking bone health nutriceutical ingredient. It is the first dietary supplement with clinical support that substantiates increased bone mineral density.
Here are the major benefits associated with Ipriflavone the most promising nutrient for the management of bone health.
Osteoporosis is the most common disease in the bones. It affects at least 28 million people in America and millions of people in United Kingdom and Europe. Osteoporosis is one of the top 3 most life threatening diseases in the United States.
Many studies show that Ipriflavone increases Bone Mineral Density significantly. The range of increase, substantiated in both pre-clinical and well controlled clinical trials, is between 3% and 9% in a short as 3 to 9 months, (the daily intake was 600mg per day in most studies). Ipriflavone is recommended to those not in the high risk category to maintain normal levels of Bone Mineral Density.
It is recommended to those at higher risk, suffering from more advanced stages of Osteoporosis, to boost bone density levels back to the safety zone. Ipriflavone was studied side by side with one of the most popular prescription drugs, Calcitonin. In the study, Ipriflavone was shown to inhibit the formation of osteoclasts and bone resorbtion, and stimulate the formation of osteoblasts. Thus, like Calcitonin, Ipriflavone increased bone mineral density. Ipriflavone was shown to inhibit bone resorption without the negative estrogenic hormone effects while supporting the effect of the body's natural estrogen support to the bone building tissues.